In this retrospective study encompassing 141 patients, we evaluated the efficacy of SC (GEMCIS and GEMOX) with or without PD-(L)1 inhibitors and HAIC plus lenvatinib and PD-(L)1 inhibitors (HLP) for the treatment of unresectable ICC. Here, CD274 is linked to intrahepatic cholangiocarcinoma.